Mannan binding lectin and its interaction with immunoglobulins in health and in disease.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 16814399)

Published in Immunol Lett on June 12, 2006

Authors

James N Arnold1, Raymond A Dwek, Pauline M Rudd, Robert B Sim

Author Affiliations

1: Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom. james.arnold@bioch.ox.ac.uk <james.arnold@bioch.ox.ac.uk>

Articles citing this

Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov (2009) 3.66

Structure and function of immunoglobulins. J Allergy Clin Immunol (2010) 2.22

Protective Roles of Natural IgM Antibodies. Front Immunol (2012) 1.48

A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes. Cell (2010) 1.17

Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method. Bioconjug Chem (2007) 1.11

Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection. Bioconjug Chem (2009) 1.08

Natural IgM: beneficial autoantibodies for the control of inflammatory and autoimmune disease. J Clin Immunol (2014) 1.01

Scabies mite peritrophins are potential targets of human host innate immunity. PLoS Negl Trop Dis (2011) 0.92

Opportunities to exploit non-neutralizing HIV-specific antibody activity. Curr HIV Res (2013) 0.91

Fundamental roles of the innate-like repertoire of natural antibodies in immune homeostasis. Front Immunol (2013) 0.89

MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses. Proc Natl Acad Sci U S A (2012) 0.89

Highly parallel characterization of IgG Fc binding interactions. MAbs (2014) 0.89

Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. Arthritis Res Ther (2012) 0.86

The contribution of mannose binding lectin to reperfusion injury after ischemic stroke. Curr Neurovasc Res (2011) 0.86

Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. Arthritis Rheum (2012) 0.85

Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes. J Proteome Res (2011) 0.84

Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children. J Infect Dis (2009) 0.84

Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants. PLoS One (2015) 0.83

Serum mannose-binding lectin levels are linked with respiratory syncytial virus (RSV) disease. J Clin Immunol (2007) 0.83

The role of the complement system in acute kidney injury. Semin Nephrol (2013) 0.83

Protective autoantibodies in the rheumatic diseases: lessons for therapy. Nat Rev Rheumatol (2013) 0.81

Lectin-based analysis of fucose and sialic acid expressions on human amniotic IgA during normal pregnancy. Glycoconj J (2012) 0.81

Hepatic gene expression profiling reveals protective responses in Atlantic salmon vaccinated against furunculosis. BMC Genomics (2009) 0.80

Rheumatoid factor and its interference with cytokine measurements: problems and solutions. Arthritis (2011) 0.80

Mannose-binding lectin blunts macrophage polarization and ameliorates lupus nephritis. PLoS One (2013) 0.78

Immunological methods for nursing research: from cells to systems. Biol Res Nurs (2011) 0.75

Estrogens regulate glycosylation of IgG in women and men. JCI Insight (2017) 0.75

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles. J Immunol Methods (2017) 0.75

Effects of soybean oligosaccharides on intestinal microbial communities and immune modulation in mice. Saudi J Biol Sci (2016) 0.75

Articles by these authors

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. J Virol (2002) 7.82

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science (2003) 6.68

The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol (2007) 4.96

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol (2002) 3.53

Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Glycobiology (2003) 3.19

Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature (2007) 3.01

Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds. Proteomics (2009) 2.93

Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol (2005) 2.82

Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature (2009) 2.81

Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology (2007) 2.71

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A (2005) 2.70

The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc Natl Acad Sci U S A (2003) 2.64

Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J Virol (2008) 2.63

Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med (2007) 2.57

Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc Natl Acad Sci U S A (2010) 2.51

Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet (2004) 2.45

Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology (2007) 2.45

Glycoprotein structural genomics: solving the glycosylation problem. Structure (2007) 2.40

Functional significance of factor H binding to Neisseria meningitidis. J Immunol (2006) 2.39

Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res (2009) 2.39

A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol (2010) 2.30

Contrasting IgG structures reveal extreme asymmetry and flexibility. J Mol Biol (2002) 2.10

The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog (2008) 2.09

Structural basis for complement factor H linked age-related macular degeneration. J Exp Med (2007) 2.02

Conformational studies of oligosaccharides and glycopeptides: complementarity of NMR, X-ray crystallography, and molecular modelling. Chem Rev (2002) 2.02

C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol (2004) 1.98

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. PLoS One (2011) 1.95

Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics (2008) 1.94

HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem (2007) 1.92

Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology (2003) 1.91

Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception. Proc Natl Acad Sci U S A (2002) 1.88

Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc Natl Acad Sci U S A (2007) 1.84

Emerging principles for the therapeutic exploitation of glycosylation. Science (2014) 1.83

Complement activation and protein adsorption by carbon nanotubes. Mol Immunol (2005) 1.81

Antiviral effects of an iminosugar derivative on flavivirus infections. J Virol (2002) 1.80

His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem (2006) 1.79

Interactions between Neisseria meningitidis and the complement system. Trends Microbiol (2007) 1.72

High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics (2011) 1.70

Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem (2003) 1.68

Glycans as cancer biomarkers. Biochim Biophys Acta (2011) 1.66

Storage solutions: treating lysosomal disorders of the brain. Nat Rev Neurosci (2005) 1.65

GlycoBase and autoGU: tools for HPLC-based glycan analysis. Bioinformatics (2008) 1.64

Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology (2005) 1.60

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology (2008) 1.55

Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet (2013) 1.52

Novel serum biomarker candidates for liver fibrosis in hepatitis C patients. Clin Chem (2007) 1.52

Genes contributing to prion pathogenesis. J Gen Virol (2008) 1.51

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood (2009) 1.51

The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells. J Biol Chem (2007) 1.51

Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C. Neurobiol Dis (2004) 1.50

Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus. Hepatology (2007) 1.49

Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal Biochem (2008) 1.49

Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem (2005) 1.47

Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat Mater (2010) 1.45

The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy. Proc Natl Acad Sci U S A (2009) 1.44

Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol Biol (2006) 1.43

Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation. PLoS Genet (2010) 1.43

Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. J Immunol (2003) 1.43

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal Biochem (2004) 1.42

Simultaneous activation of complement and coagulation by MBL-associated serine protease 2. PLoS One (2007) 1.42

Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody. Angew Chem Int Ed Engl (2004) 1.41

Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody. J Mol Biol (2007) 1.41

Molecular mechanism of lipopeptide presentation by CD1a. Immunity (2005) 1.41

Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem (2004) 1.40

C1q and its growing family. Immunobiology (2006) 1.40

Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. Glycobiology (2010) 1.39

Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood (2003) 1.39

Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology (2010) 1.37

The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors. J Biol Chem (2006) 1.36

Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem (2010) 1.36

A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120. J Virol (2008) 1.34

Novel glycan biomarkers for the detection of lung cancer. J Proteome Res (2011) 1.33

Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J Virol (2007) 1.33

Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Glycobiology (2003) 1.32